Home - Products - GPCR/G Protein - SGLT - Sergliflozin A

Sergliflozin A

CAS No. 360775-96-8

Sergliflozin A( —— )

Catalog No. M36251 CAS No. 360775-96-8

Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	170	Get Quote
5MG	247	Get Quote
10MG	371	Get Quote
25MG	601	Get Quote
50MG	854	Get Quote
100MG	1134	Get Quote
500MG	2277	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Sergliflozin A
Note

Research use only, not for human use.
Brief Description

Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.
Description

Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

GPCR/G Protein
Target

SGLT
Recptor

SGLT
Research Area

——
Indication

——

Chemical Information

CAS Number

360775-96-8
Formula Weight

376.4
Molecular Formula

C20H24O7
Purity

>98% (HPLC)
Solubility

——
SMILES

O(C1=C(CC2=CC=C(OC)C=C2)C=CC=C1)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Enavogliflozin

Enavogliflozin is an orally available small molecule and sodium glucose transporter 2 inhibitor.
Sergliflozin A

Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.
Canagliflozin

A highly potent and selective SGLT2 inhibitor with IC50 of 4.4, 3.7 and 2.0 nM for hSGLT2, rSGLT2 and mSGLT2, respectively.

Sign In Join Free